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Background: The objectives of the present study were to investigate the efficacy of the mixed culture of
Lactobacillus acidophilus (DSM 20242), Bifidobacterium bifidum (DSM 20082) and Lactobacillus helveticus (CK60) in the
fermentation of maize and the evaluation of the effect of the fermented meal on the lipid profile of rats.
Methods: Rats were randomly assigned to 3 groups and each group placed on a Diet A (high fat diet into which a
maize meal fermented with a mixed culture of Lb acidophilus (DSM 20242), B bifidum (DSM 20082) and Lb helveticus
(CK 60) was incorporated), B (unfermented high fat diet) or C (commercial rat chow) respectively after the first
group of 7 rats randomly selected were sacrificed to obtain the baseline data. Thereafter 7 rats each from the
experimental and control groups were sacrificed weekly for 4 weeks and the plasma, erythrocytes, lipoproteins and
organs of the rats were assessed for cholesterol, triglyceride and phospholipids.
Results: Our results revealed that the mixed culture of Lb acidophilus (DSM 20242), B bifidum (DSM 20082) and
Lb helveticus (CK 60) were able to grow and ferment maize meal into ‘ogi’ of acceptable flavour. In addition to
plasma and hepatic hypercholesterolemia and hypertriglyceridemia, phospholipidosis in plasma, as well as
cholesterogenesis, triglyceride constipation and phospholipidosis in extra-hepatic tissues characterized the
consumption of unfermented hyperlipidemic diets. However, feeding the animals with the fermented maize diet
reversed the dyslipidemia.
Conclusion: The findings of this study indicate that consumption of mixed culture lactic acid bacteria
(Lb acidophilus (DSM 20242), Bifidobacterium bifidum (DSM 20082) and Lb helveticus (CK 60) fermented food results
in the inhibition of fat absorption. It also inhibits the activity of HMG CoA reductase. This inhibition may be by
feedback inhibition or repression of the transcription of the gene encoding the enzyme via activation of the sterol
regulatory element binding protein (SREBP) transcription factor. It is also possible that consumption of fermented
food enhances conversion of cholesterol to bile acids by activating cholesterol-7α-hydroxylase.
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The applications of probiotics have been well established
throughout generations. The interest in the microorgan-
isms in the recent years emanated from the discovery of
their salubrious effect in lowering plasma cholesterol.
The reported health promoting ability of LAB in humans
and livestock include the inhibition of pathogenic micro-
organisms [1,2], increase in immune response [3,4], re-
duction of serum cholesterol levels [5] and neutralization
of food mutagens produced in the colon and halting of
intestinal dysfunction [6].
Epidemiological data and clinical studies indicate a
positive correlation between elevated total serum choles-
terol levels, mainly reflecting the LDL-cholesterol, and
the development of atherosclerosis and related cardio-
vascular disease [7,8]. Dietary interventions that lower
the intake of saturated fat and cholesterol are established
as a first line therapy to reduce LDL-cholesterol. Con-
sumption of fermented products containing LAB has
been reported to reduce cholesterol [9-12].
A combination of different mechanisms has been pro-
posed for the cholesterol lowering ability of LAB in
humans. These include: (i) interaction of bile salt hydro-
lase of the lactic acid bacteria with the host’s bile salt
metabolism. The resultant effect is the reduction in re-
absorption of bile salts, loss of feedback inhibition of the
bile salt synthesis and increased conversion of choles-
terol to bile salts [13-15] (ii) lowering of 3-hydroxy-3-
methyl glutaryl-CoA (HMG-CoA) reductase activity, a
major regulatory enzyme in cholesterol biosynthesis
[6,16]. However, for the LAB to be effective in this func-
tion, they must be tolerant to the acid and bile as well as
inhibit the putrefactive bacteria in the gastrointestinal
tract (GIT) of the host [6].
Although the hypocholesterolemic effects of probiotics
are supported by a large body of research, most of these
studies were confined to lipid dynamics of the plasma/
serum [17-19] with only a few studies on tissue lipids
[20,21]. Cholesterol and triglycerides have been the com-
ponents of major interest with very little attention being
given to plasma phospholipids, erythrocyte lipid profile,
as well as lipid profiles of the tissues.
Consumption of the LAB fermented dairy products
serve as convenient vehicle for introducing LAB with
the desired characteristics into the gut. An alternative is
the consumption of fermented cereal products widely
utilized in developing countries where milk is either un-
available or unaffordable. Many African foods are fer-
mented before consumption. In general, there are two
major substrates for fermentation. These are cereal
grains including maize, sorghum, and millet which are
fermented into alcoholic beverages such as ‘burukutu’
and ‘pito’ or non-alcoholic beverage and meals such as
‘kunnu’ and ‘ogi’ or ‘agidi’ which are taken as maincourse meals. The second major substrate is cassava
which is also subjected to acidic fermentation to pro-
duce meals such as ‘gari’, ‘fufu’ and ‘lafun’. In almost all
the cases, the fermentation is initiated by chance inocu-
lation. Lactic acid bacteria (LAB) have been identified as
the predominant microorganisms in these acid fermen-
tations [22].
The objectives of the present study were to investigate
the efficacy of the mixed culture of Lb acidophilus (DSM
20042), Bifidobacterium bifidum (DSM 20082) and Lb
helveticus (CK 60) which are gut inhabiting microorgan-
isms in the fermentation of maize as a model of cereal
fermentation in sub-Saharan Africa and the evaluation
of the effect of the fermented meal on the lipid profile of
the plasma, erythrocytes, the lipoproteins as well as six
selected organs of wistar strain albino rats.
Materials and Methods
Preparation of inoculum
Mixed culture lactic acid bacteria comprising of Lb acid-
ophilus (DSM 20242), Lb helveticus (CK 60) and Bifido-
bacterium bifidum (DSM20082) was cultivated on MRS
agar slant (37°C, 48 hr). To harvest the grown culture,
sterile distilled water (10 ml) was added and shaken vig-
orously to dislodge the cells into the distilled water and
the cells suspension was used to inoculate the sterile
maize mash.
Preparation of mixed culture LAB fermented maize mash
Cleaned maize grains (2 kg) were ground in a disc attri-
tion mill (3 times). The maize meal obtained was
weighed (500 g) into autoclavable bags (Fisher Scientific
Company, U.S.A.) and sterilized (121°C, 15 min). After
cooling to about 25°C, sterile distilled water (800 ml)
was aseptically added and mixed thoroughly. The packs
of sterile marsh were divided into two and half of the
packs were inoculated with 10 ml suspension of the
mixed culture LAB while 10ml distilled water was added
to the remaining half to serve as control. All the packs
were incubated (37o, 48 hr). At the end of fermentation,
the products obtained were dried in an air oven (45°C,
48 hr).
Analysis of the fermenting marsh
To monitor the fermentation process, chemical as well
as microbiological analyses were carried out at regular
intervals.
Microbiological analyses
At regular intervals (12 hrs), samples of the fermenting
mash (1 g) was aseptically removed and mixed with ster-
ile water (10 ml). The suspension obtained was serially
diluted and plated in triplicate. Dilutions (10-4 and 10-6)
were plated on MRS agar for total count. The MRS
Table 2 Proximate composition of the high fat diet and
the commercial rat chow









*Two types of high fat diet were prepared, one with mixed culture of
Lb acidophilus, Lb helveticus and Bifidobacterum bifidum fermented maize meal
(Diet A) and the other unfermented maize meal (Diet B).
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incubation, the colonies on each plate were counted and
the mean of triplicate determination estimated.
Chemical analyses
Sample of the mash (5g) was aseptically removed at
regular interval and mixed with distilled water (25ml).
The pH of the resulting suspension was then measured
after the pH meter had been calibrated using pH 7.0 and
pH 4.0 buffers. The mash suspension was then used in
titration with 0.1N NaOH solution to pH 8.3. The rela-
tive amount of lactic acid present was calculated as per-
cent lactic acid on dry matter basis [23].
Feeding trial
Experimental protocols were conducted in accordance
with guidelines of the Institutional Animal Care and Use
Committee and were approved by the Animal Ethical
Committee of the Department of Biochemistry, Faculty
of Basic Medical Sciences, Olabisi Onabanjo University,
Ikenne-Remo, Nigeria. A total of ninety-one wistar strain
albino male rats obtained from the animal house of the
Faculty of Basic Medical Sciences of Olabisi Onabanjo
University, Ikenne-Remo, Nigeria were housed individu-
ally in cage and maintained on a 12 hr light–dark cycle.
Temperature and humidity were controlled at 25°C and
60% respectively. The rats were randomly assigned to 3
groups and each group placed on a Diet A, B or C re-
spectively after the first group of 7 rats randomly
selected were sacrificed to obtain the baseline data.
Thereafter 7 rats each from the experimental and con-
trol groups were sacrificed weekly for 4 weeks and the
plasma, erythrocytes, lipoproteins and organs of the rats
were assessed for cholesterol, triglyceride and phospholi-
pids. The high fat diets A and B were compounded as
shown in Tables 1 and 2. The maize meal incorporated
into each diet was either fermented with mixed culture
of Lb acidophilus (DSM 20242), Lb helveticus (CK 60)Table 1 Composition of the high fat diets
Ingredient g/kg diet
Maize (fermented or unfermented)* 500
Full cream powdered milk 300






*The maize meal incorporated into the diet was either fermented with
mixed culture of Lb acidophilus, Lb helveticus and Bifidobacterum bifidum to
produce high fat-fermented diet i.e. Diet A or unfermented to produce high
fat-unfermented diet i.e. Diet B respectively.and Bifidobacterum bifidum (DSM 20082) to produce
high fat-fermented diet i.e. Diet A or unfermented to
produce high fat-unfermented diet i.e. Diet B respect-
ively. Diet C was commercial rat chow purchased from
Ladokun Feeds, Ibadan, Nigeria.Biochemical Analysis
Plasma and lipoprotein lipid profiles
Plasma concentrations of total cholesterol and triglycer-
ides were determined with commercial kits (Spin React
S.A., Santa Colona, Sant Esteve De Bas, Spain). High
density lipoprotein (HDL) cholesterol and triglycerides
were determined in plasma with same commercial kits
for total cholesterol and triglycerides after very low
density lipoproteins (VLDL) and Low density lipoprotein
(LDL) were precipitated with heparin-MnCl2 solution as
described by Gidez et al. [24]. Total phospholipids in
plasma were extracted with chloroform-methanol mix-
ture (2:1, v/v) as described by Folch et al. [25]. Phospho-
lipids content was then determined as described by
Stewart [26].Organ and erythrocyte lipid profiles
Lipids were extracted from organs and erythrocytes as
described by Folch et al. [25]. After washing with 0.05M
KCl solution, aliquots of the chloroform-methanol ex-
tract were then used for the determination of choles-
terol, triglycerides and phospholipids concentrations. An
aliquot of the chloroform-methanol extract was evapo-
rated to dryness at 60°C. 20 μl of Triton X-100/chloro-
form mixture (1:1, v/v) was added to dissolve the lipids
and again the solvent was evaporated. Then 1ml of com-
mercially available cholesterol kit reagent (Spin React S.
A., Santa Colona, Sant Esteve De Bas, Spain) was added
and vortexed. After incubation in the dark at room
temperature for 30 min, cholesterol content was deter-
mined by colorimetry while determination of
Table 4 Changes in pH and total acidity in mixed culture
LAB fermenting maize meal and the uninoculated meal









12 hrs 6.4 ± 0.1 6.3 ± 0.1 0.26 ± 0.01 0.26 ± 0.02
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for plasma.
Triglyceride concentrations in aliquots of the
chloroform-methanol extracts of the tissues were deter-
mined following the procedure described by Kriketos
et al. [27].24 hrs 5.6 ± 0.1 6.2 ± 0.05 0.96 ± 0.02 0.42 ± 0.03
48 hrs 4.1 ± 0.3 5.8 ± 0.1 2.2 ± 0.1 0.84 ± 0.1Determination of HMG-CoA reductase activity in the liver
HMG-CoA reductase was determined according to the
method of Rao and Ramakrishnan [28] by measuring the
ratio of the concentrations of 3-hydroxy-3-methyl-glu-
taryl CoA (HMG CoA) and mevalonate in the liver. The
ratio was taken as an index of the activity of HMG CoA
reductase. An increase in this ratio indicates inhibition












Results are expressed as mean ± SD. One way analysis of
variance (ANOVA) followed by Tukey’s test was used to




















































   
   
   
   
   
   





























Fermentation of maize mash
The total plate count of the LAB during the fermenta-
tion of the maize mash showed that LAB population
increased from 4.8 × 105 CFU/g at 12 hrs after inocula-
tion to 3.6 × 109 CFU/g at the end of 48 hrs after inocu-
lation. There was no growth in the uninoculated maize
mash within the first 24 hrs. A total of 3.1 × 103 CFU/g
was recorded after 48 hrs (Table 3).
There were no significant changes in pH and total
acidity of the LAB inoculated and uninoculated maize
mash within the first 12 hrs (Table 4). However, at the
end of the 48 hrs fermentation, the pH decreased to 4.1
± 0.3 and the acidity rose to 2.2 ± 0.1% in the maize
mash inoculated with mixed culture LAB while in the
unfermented, the pH decreased to 5.8 ± 0.1 and the ti-
tratable acidity rose to 0.84 ± 0.1% within the same
period. The flavour and taste of the LAB fermented
maize mash were reminiscent of those of yoghurt indica-
tive of acceptable “ogi”, the traditional cereal porridge








12 4.8 × 105 0
24 2.9 × 109 0
48 3.6 × 109 3.1 × 103Biochemical analyses
Plasma and lipoprotein lipid profile
The results of cholesterol, triglyceride and phospholipid
concentrations in the plasma and HDL as well as VLDL
cholesterol are shown in Figures 1, 2, 3. Figure 1 shows
the plasma lipid profiles of the animals placed on high
fat diets containing LAB fermented maize mash, Diet A

















   
   
   
   
   
   
   
   
   
 (
m
Figure 1 Plasma lipid concentrations of the animals – A











































































































Figure 2 HDL lipid concentrations of the animals – A




































Figure 3 VLDL cholesterol concentration of the animals.
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http://www.lipidworld.com/content/11/1/170rat chow, Diet C. Consumption of the unfermented and
normal diets (Diets B and C) resulted in hypercholester-
olemia, hypertriglyceridemia and hyperphospholipidemia
in the animals. These alterations were noticed from the
first week till the end of the four-week feeding period.
By the fourth week of consumption of these two diets,
there was a 3-fold increase in the plasma concentrations
of cholesterol, triglycerides and phospholipids. In con-
trast however, ingestion of the fermented diet, Diet A,
reversed this trend.
The amount of lipid transported by the HDL is
depicted in Figure 2. Compared to normal and fermen-
ted diets, consumption of the unfermented diet resultedin a significant increase (P < 0.05) in the amount of lipid
transported by this lipoprotein during the four-week ex-
perimental period. While cholesterol increased by 2.5
fold, a 5-fold increase was observed in the triglycerides
while phospholipids increased 2-fold. Although HDL
cholesterol also increased as a result of the consumption
of the normal and fermented diets, the increase was
steady and gradual and amounted to just 68% of that of
the animals consuming the unfermented diet. The
amount of triglyceride and phospholipid transported by
the HDL was not significantly affected by the consump-
tion of the fermented diet.
In the VLDL (as depicted in Figure 3), consumption of
the normal and unfermented diets resulted in a signifi-
cant increase (P < 0.05) in the amount of cholesterol
found in this lipoprotein. Comparatively, by the end of
the four-week feeding period, cholesterol found in this
lipoprotein was about 5 times baseline value in the ani-
mals consuming both the normal and unfermented diets,
whereas consumption of the fermented diet did not
seem to have any significant effect on the cholesterol
content of this lipoprotein.
Figure 4 shows the erythrocyte lipid concentrations of
the rats. While a systematic increase in all the lipids
investigated characterised the effects of the consumption
of the unfermented diet in the erythrocyte of these rats,
the lipid lowering effects of the consumption of the fer-
mented diet was unsystematic.
Hepatic lipid contents of the animals as shown in Fig-
ure 5 indicate that consumption of the normal and un-
fermented diets resulted in hepatic cholesterogenesis,
triglyceride constipation and phospholipidosis. While
the cholesterogenesis was more pronounced in rats con-
suming the normal diet, hepatic triglyceride constipation
and phospholipidosis were more pronounced in animals
consuming the unfermented diet. Consumption of the


















































































































Figure 4 Erythrocyte lipid concentrations of the animals – A






































































































































Figure 5 Hepatic lipid concentrations of the animals – A
(Cholesterol), B (Triglycerides) and C (Phospholipids).
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spleen, heart and lungs (Figures 6, 7, 8, 9, 10), a general
pattern of lipid dynamics characterised the effects of in-
gestion of the diets. In these tissues, consumption of the
unfermented diet resulted in excessive accumulation of
cholesterol, triglyceride and phospholipids, whereas
feeding the animals with the fermented diet reversed this
trend.
Figure 11 depicts hepatic HMG CoA/Mevalonate ratio
as an index of the activity of HMG CoA reductase. The
activity of the enzyme increased in the liver as a result
of the consumption of unfermented high fat diet,
whereas the enzyme was inhibited in the rats fed with
the fermented high fat diet.Discussion
The use of probiotics has gained scientific recognition in
recent years even though their applications as functional
foods have been well established throughout generations.
The ability of the gut inhabiting bacteria in particular Lb
acidophilus (DSM 20242), Bifidobacterium bifidum
(DSM 20082) and Lb helveticus (CK 60) to grow and fer-
ment cereal into acceptable “ogi” with characteristics
comparable to the traditional “ogi” in which Lb plan-
tarum among other lactics is the predominant ferment-



































































































































Figure 6 Renal lipid concentrations of the animals – A


































































































































Figure 7 Brain lipid concentrations of the animals – A
(Cholesterol), B (Triglycerides) and C (Phospholipids).
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itionally consumed in sub Saharan Africa.
The scientific and commercial interests in these live
micro-organisms derive from the range of physiological
and health effects/benefits which these bacteria confer
on the host, most especially on lipid metabolism [17,20].
In our study, we investigated the lipid dynamics of the
plasma, erythrocytes, the lipoproteins as well as six
organs in albino rats fed high fat diets, one containing
mixed culture LAB fermented maize meal and the other
unfermented maize meal.
The results of this study indicate that feeding rats with
normal and unfermented hyperlipidemic diets resulted
in perturbations in lipid metabolism in different com-
partments of the animals. These perturbations werecharacterized by up-regulation of the concentrations of
the major lipids (cholesterol, triglyceride and phospholi-
pids) not only in the plasma, but also in all the organs
(liver, kidney, brain, heart, lungs and spleen) examined.
These observations suggest that interaction between
the normal and unfermented hyperlipidemic diets and
the major lipids went beyond the level of the gastrointes-
tinal tract each week resulting in enhanced tissue uptake
and/or de novo synthesis of these lipids in all the tissues
examined during the four week feeding period. While
the observation of up-regulation of plasma and hepatic
cholesterol and triglycerides is in agreement with the
results of other workers [20], the effects of consump-



































































































































Figure 8 Spleen lipid concentrations of the animals – A







































































































































Figure 9 Cardiac lipid concentrations of the animals – A
(Cholesterol), B (Triglycerides) and C (Phospholipids).
Banjoko et al. Lipids in Health and Disease 2012, 11:170 Page 8 of 11
http://www.lipidworld.com/content/11/1/170phospholipids on one hand, as well as the effects on the
major lipids of other extra-hepatic tissues on the other
hand, have not been reported. Our results thus suggest
that in addition to plasma and hepatic hypercholesterol-
emia and hypertriglyceridemia, phospholipidosis in
plasma, as well as cholesterogenesis, triglyceride consti-
pation and phospholipidosis in extra-hepatic tissues,
characterize the consumption of unfermented hyperlip-
idemic diets. Particularly striking was that these effects
were also observed in the brain.
Mechanistically, enhanced cholesterogenesis observed
in the liver and brain of the animals may be attributed
to activation of HMG CoA reductase (Figure 11), while
the accumulation of cholesterol by the kidney, heart,lungs and spleen during this feeding period may be
mediated by an enhanced cholesterol efflux from the
liver since most extra-hepatic tissues depend on the liver
for their cholesterol needs [30].
The immediate substrates for triglyceride and
phospholipid synthesis are the free fatty acids (FFA)
[31]. They are also the major source of energy in
many tissues [32]. The excessive accumulation of tri-
glycerides in the tissues upon consumption of the normal
and unfermented hyperlipidemic diets indicates that
most of the absorbed FFA was directed towards the syn-












































































































Figure 10 Lungs lipid concentrations of the animals – A





























Figure 11 HMG CoA/Mevalonate ratio as an index of the
activity of HMG CoA reductase.
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ing energy production in these tissues.
Phospholipidosis is a lipid storage disorder in which
abnormal quantities of phospholipids accumulate in
various tissues [30,33]. The induction time may be a few
days to several months [30,33-35]. Four major concepts
have been proposed for the mechanism of induction of
phospholipidosis: (1) inhibition of lysosomal phospholip-
ase activity – this is generally regarded as the primary
mechanism of induction, (2) inhibition of lysosomal en-
zyme transport as a result of down-regulation of genes
involved in lysosomal enzyme transport, (3) enhanced
phospholipid biosynthesis due to enhanced FFA avail-
ability and (4) enhanced cholesterogenesis [34]. Our data
indicate that the last two mechanisms might be involved
in the induction of phospholipidosis in tissues as a resultof consumption of normal and unfermented hyperlipid-
emic diets. Although we did not determine the activity
of phospholipase in this study, an inhibition of this en-
zyme by the diets cannot be ruled out.
Another major finding of this study was that feeding
the animals with the LAB fermented maize diet reversed
the dyslipidemia induced by the consumption of the un-
fermented hyperlipidemic diet. Several interpretations of
this observation could be considered. Firstly, that the
fermented diet reduced plasma cholesterol, triglycerides
and phospholipids suggests that the effects of the fer-
mented diet began at the level of the gastro-intestinal
tract, inhibiting absorption of these lipids. Cholesterol
reduction by lactic acid bacteria has been attributed to
the ability of these bacteria to bind cholesterol in the
small intestine [36]. Our data (Figure 1) indicate that in
addition to cholesterol, triglycerides and phospholipids
are also bound by these micro-organisms resulting in
their decreased absorption and in a homeostatic re-
sponse, resulting in lowering of these plasma lipids. Sec-
ondly, as regards lipid metabolism in the tissues,
ingestion of the fermented diet inhibited the activity of
HMG CoA reductase, thus reducing the amount of chol-
esterol synthesized in the liver and brain. Consistent
with this was the observation of reduced cholesterol
content of the extra-hepatic tissues since their choles-
terol is obtained from the liver. In addition to reducing
hepatic cholesterol, hepatic triglycerides and phospholi-
pids, as well as extra-hepatic tissue lipids were also
decreased by ingestion of the lactic acid fermented diet.
Kitawaki et al. [20] reported that soy yogurt (prepared
using lactic bacteria) fed to rats down-regulated the gene
encoding Elovl 6, the elongase of fatty acid which cata-
lyses the conversion of palmitate to stearate. Glycerol-3-
phosphate acyl-transferase (involved in triacylglycerol
and phospholipid synthesis), was also down-regulated
[20]. Furthermore, soy yogurt ingestion up-regulated the
Banjoko et al. Lipids in Health and Disease 2012, 11:170 Page 10 of 11
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β-oxidation of fatty acids [20]. The authors concluded
that suppression by soy yogurt of hepatic lipids in these
animals depended on the regulation of synthesis and
degradation of lipids at the gene level. The same
mechanisms may be assumed for the down regulation of
tissue lipids observed in our study.
The fermented diet also promoted a significant in-
crease in HDL-cholesterol. This is an important factor
since HDL-cholesterol can prevent arteriosclerosis. Al-
though the unfermented diet also promoted a significant
increase in HDL-cholesterol, the increase observed in
total plasma cholesterol in this group of animals appar-
ently obviates any potential benefit that the high HDL-
cholesterol might bring.
Our data on erythrocyte lipid dynamics warrant fur-
ther studies. While the unfermented diet was consistent
in promoting increase in erythrocyte lipids, inconsisten-
cies observed in the effects of the fermented diet make
any interpretation of data difficult.
In conclusion, the findings of this study indicate that
consumption of mixed culture lactic acid bacteria (Lb
acidophilus (DSM 20242), Bifidobacterium bifidum
(DSM 20082) and Lb helveticus (CK 60) fermented food
results in the inhibition of fat absorption. It also inhibits
the activity of HMG CoA reductase. This inhibition may
be by feedback inhibition or repression of the transcrip-
tion of the gene encoding the enzyme via activation of
the sterol regulatory element binding protein (SREBP)
transcription factor. It is also possible that consumption
of fermented food enhances conversion of cholesterol to
bile acids by activating cholesterol-7α-hydroxylase.
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